AI Public Relations for Biotech & Pharma

The Public Relations challenge for Biotech & Pharma

The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.

On Public Relations specifically, Biotech & Pharma teams run into: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute

How CoMo's PR Agent runs Public Relations for Biotech & Pharma

AI scans journalist social feeds and wires in real time to surface pitch hooks within hours of a news hook — days faster than a human monitoring manually. The agent reads Muck Rack / Cision journalist database (beats, recent articles, contact details), Google Alerts and media monitoring feed (brand and competitor mentions), Company newsroom and press release history, Competitor PR activity (new funding, product launches, executive moves) and runs: Maintain a tiered media contact database segmented by beat, outlet, and prior coverage history; Monitor news wires and journalist social feeds for pitch hooks relevant to company announcements; Draft personalized press pitches and embargo notes for product launches and funding events; Track earned media coverage (mentions, sentiment, DA of covering outlets); Issue media corrections and follow-up sequences when coverage contains factual errors; Produce a quarterly share-of-voice report vs named competitors across target publications — applied to Biotech & Pharma context.

For Biotech & Pharma that means coordinated execution across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships without adding headcount, with a human approval gate before anything publishes or spends.

What you get

Outputs: Personalized pitch drafts ready for human review and send, Coverage log (outlet, journalist, sentiment, DA, date), Monthly share-of-voice report vs top 3 competitors, Media contact database (clean, de-duplicated, updated quarterly) — tuned to Biotech & Pharma buyers (VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma) and moving Earned media mentions per month (tier-1, tier-2 separately), Share of voice % vs primary competitors, Domain authority of covering outlets (avg). The PR Agent works alongside CoMo's other agents so Public Relations stays aligned with the rest of your marketing.

RELATED